-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Dengue virus
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- Flavivirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Nipah virus
- Orthopoxvirus
- Others
- Rabies virus (RABV)
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Tobacco mosaic virus (TMV)
- Vesicular stomatitis virus (VSV)
- Virus Protease
- West Nile virus
- Antiviral intermediates
Morin-3-O-β-D-glucopyranoside
![{PARAM:[Name]}()](https://resource.bocsci.com/structure/1169766-14-6.gif)
| Category | Hepatitis C Virus (HCV) |
| CAS | 1169766-14-6 |
| Description | Morin 3-O-β-D-glucopyranoside is a natural flavonoid with antifungal, anticancer and antioxidant activities. Morin 3-O-β-D-glucopyranoside inhibits reverse transcriptase, protein-tyrosine kinase and xanthine oxidase, and also shows anti-HIV, antiarteriosclerotic, and superoxide scavenging activities. |
Product Information
| Molecular Weight | 464.38 |
| Molecular Formula | C21H20O12 |
| Boiling Point | 875.2±65.0 °C |
| Purity | ≥98% (HPLC) |
| Density | 1.87±0.1 g/cm3 |
| Solubility | In vitro: 10 mM in DMSO |
| Appearance | Solid powder |
| Storage | Store at -20°C |
| In Vitro | Morin 3-O-β-D-glucopyranoside suppresses the cell viability of HepG2, HCT116 and HT29 cell lines to 11.20%, 22.19% and 38.11% as compared to control. Morin 3-O-β-D-glucopyranoside shows a very significant anti-lipid peroxidation activity. |
| Target | Reverse Transcriptase; HIV; Xanthine Oxidase |
